Overview
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-05-28. Active
04 1090 1522 0000 0001 4244 4390- 23 1090 1522 0000 0001 4244 4436
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 30, 2019 | Aid for SME access to finance — aid for start-ups | $177.1K$177,093 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 1,028 | $13,884.39 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Paweł Czesław Biernat (51)  | Członek zarządu wspólnika biotts s.a., który posiada ponad 25% udziałów w spółce ngd pharma sp. z o.o. paweł biernat zgłoszony jest jako beneficjent rzeczywisty biotts s.a. na podstawie art. 2 ust. 2 pkt 1a) tiret 5 upppoft |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| Meritrosp. z o.o. | $7,890.74 | meritro.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| MAP Your Dna Spólka z Ograniczoną Odpowiedzialnościąsp. z o.o. | $7,283.38 | mapyourdna.eu | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| Olenasp. z o.o. | — | imsolutions.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-06-04 | Business resumed | |
| 2024-06-03 | Business suspended | |
| 2022-05-20 | Address change (Ul. Duńska 7, 54-427, Wrocław → Wrocławska 44c, 55-040, Bielany Wrocławskie) | |
| 2022-01-11 | Share capital change (6,600.00 PLN → 51,400.00 PLN) | |
| 2021-06-24 | Share capital change (6,550.00 PLN → 6,600.00 PLN) |
FAQ
Last updated: 2026-06-04